Common Therapeutic Modalities Against Diabetes and Associated Cardiovascular Disease

Area of Science:

• Medical research
• Pathophysiology
• Pharmacology

Background:

• Rising incidence of fatal events linked to diabetes and cardiovascular disease (CVD).
• Overlapping pathophysiological pathways including hyperglycemia, insulin resistance, obesity, and oxidative stress contribute to disease progression.
• Current treatments often address conditions separately, despite shared underlying mechanisms.

Purpose of the Study:

• To review the shared pathological mechanisms between diabetes and CVD.
• To identify potential common therapeutic strategies for both diseases.
• To highlight drugs that could simultaneously target diabetes and associated cardiovascular complications.

Main Methods:

• Literature review of studies on diabetes, CVD, and their co-occurring pathways.
• Analysis of pathophysiological alterations common to both conditions.
• Identification of existing drugs with potential dual therapeutic action.

Main Results:

• Multiple shared pathways initiate and progress atherosclerotic plaques in both diabetes and CVD.
• Key alterations include hyperglycemia, hyperinsulinaemia, insulin resistance, obesity, endothelial dysfunction, and oxidative stress.
• Several existing medications show promise for targeting these common pathways.

Conclusions:

• A critical need exists for integrated treatment approaches for diabetes and CVD.
• Common drugs targeting shared pathophysiological mechanisms offer a promising strategy to reduce fatal events.
• Further research into dual-acting therapies is warranted to improve patient outcomes.